CNS/Neurology Market Research Reports & Industry Analysis
A neurologist is a medical doctor that specializes in the diagnosis, treatment and management of illnesses affecting the brain, spinal cord, and nervous system. Neurologists must complete at least three years of specialized training in neurology, after completing medical school. A neurosurgeon must go through much more extensive and rigorous schooling and training. On top of diagnosing and treating neurological disorders, neurosurgeons can also perform surgery on the brain, spinal cord, and nerves.
Pharmaceuticals in CNS/Neurology are one of leading fields in medicine in terms of funding and research. On top of growing patient numbers, there remains a comparatively high unmet need in treatment of many neurological diseases. With the potential of being one of the most lucrative therapy areas in the future pharmaceutical Industry, Alzheimer's disease offers the greatest commercial opportunity for pharmaceutical companies in neurology. Many of the therapeutic drugs used to treat CNS/Neurological disorders have lost their patent protection or market exclusivity, leading to greater research and market opportunities for competing pharmaceutical and medical device companies. Despite the widespread use of CNS drugs, knowledge of these agents is limited due to the anatomic and neurochemical complexity of the brain and spinal cord.
CNS/Neurology Industry Research & Market Reports
-
Fluoroscopy Devices Market: By Disease Pathology (Gastrointestinal, Urology, Orthopedic, Cardiovascular, Pain Management and Trauma, Neurology, General Surgery and Others); By Product type (Fixed Fluoroscopy devices, C-arm), And Region – Global Analysis of Market Size, Share & Trends For 2021–2022 And Forecasts To 2032
... & Trends For 2021–2022 And Forecasts To 2032 Fluoroscopy Devices Market: By Disease Pathology (Gastrointestinal, Urology, Orthopedic, Cardiovascular, Pain Management and Trauma, Neurology, General Surgery and Others); By Product type (Fixed Fluoroscopy devices, C-arm), And ... Read More
-
Nanotechnology Drug Delivery Market By Formulation (Lipid-based nanomedicine, Polymer-based nanomedicine, Nanocrystals, Others), By Application (Oncology and Hematology, Infectious diseases, Orthopedics, Neurology, Urology, Immunology, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
... market was valued for $87.5 billion in 2022 and is estimated to reach $209.5 billion by 2032, exhibiting a CAGR of 9.1% from 2023 to 2032. Nanotechnology is a scientific field that involves manipulating matter ... Read More
-
Vertigo Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Vertigo Clinical trials scenario. This report provides top line data relating to the clinical trials on Vertigo. Report includes ... Read More
-
Pharmaceuticals Market Covering Cardiovascular Drugs; Dermatology Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Anti-Infective Drugs; Metabolic Disorders Drugs; Musculoskeletal Disorders Drugs; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Respiratory Diseases Drugs; Vaccines; Therapeutic Nutrients & Minerals; Substance Abuse And Addiction; Global Summary 2023
... & Minerals; Substance Abuse And Addiction; Global Summary 2023 Global pharmaceuticals market was worth $1596.4 billion in 2022. In terms of per capita consumption, the market was $204.6 and in terms of global GDP, the ... Read More
-
Narcolepsy Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... prevalent cases of narcolepsy in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. The majority of marketed drugs for the treatment of narcolepsy are transport inhibitors and receptor agonists. The narcolepsy pipeline consists ... Read More
-
Dementia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Dementia Clinical trials scenario. This report provides top line data relating to the clinical trials on Dementia. Report includes ... Read More
-
Post-Traumatic Stress Disorder (PTSD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Post-Traumatic Stress Disorder (PTSD) Clinical trials scenario. This report provides top line data ... Read More
-
Dementia Drugs Market by Indication (Lewy Body Dementia, Parkinson’s Disease Dementia, Alzheimer’s Disease, Vascular Dementia, and Others), Drug Class (Cholinesterase Inhibitors, NMDA Antagonists and its Combination Drugs), Distribution Channel (Retail Ph
... and Region 2023-2028 Market Overview: The global dementia drugs market reached US$ 16.95 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 27.7 Billion by 2028, exhibiting a growth rate (CAGR) ... Read More
-
Global Digital Mental Health Market 2023-2030
... Disorder Type (Anxiety Disorder, Bipolar Disorders, Post-traumatic Stress Disorder (PSTD), and Others (depression, and eating disorders)), by End-User (Hospitals, Mental Healthcare Centers, and Research Institutes) Forecast Period (2022-2030) The global digital mental health market is ... Read More
-
Anxiety and Panic Disorders Drugs Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type
... 2018 to 2022 and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, demand, major ... Read More
-
The World Market for Opium Alkaloids, Their Derivatives, and Salts Thereof: A 2024 Global Trade Perspective
... opium alkaloids, their derivatives, and salts thereof. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years ... Read More
-
Global Neurology Clinical Trials Market Size study & Forecast, by Phase (Phase I, Phase II, Phase III, Phase IV) by Study Design (Interventional, Observational, Expanded Access), by Indication (Epilepsy, Parkinson's Disease (PD), Huntington's Disease, Stroke, Traumatic Brain Injury (TBI), Others) and Regional Analysis, 2023-2030
... Traumatic Brain Injury (TBI), Others) and Regional Analysis, 2023-2030 Global Neurology Clinical Trials Market is valued at approximately USD 5.24 billion in 2022 and is anticipated to grow with a healthy growth rate of more ... Read More
-
Global Advanced Drug Delivery Systems Market Size study & Forecast, by Type ( Oral Drug Delivery System, Injection-based Drug Delivery System, Inhalation/Pulmonary Drug Delivery System, Transdermal Drug Delivery System, Trans mucosal Drug Delivery System, Carrier-based Drug Delivery System and Other Types) by Application ( Cardiovascular Diseases, Oncology, Urology, Diabetes, Central Nervous System, Ophthalmology and Others), by Technology ( Prodrug, Implants and Intrauterine Devices, Targeted Drug Delivery, Polymeric Drug Delivery and Other Technologies) and Regional Analysis, 2023-2030
... Drug Delivery System and Other Types) by Application ( Cardiovascular Diseases, Oncology, Urology, Diabetes, Central Nervous System, Ophthalmology and Others), by Technology ( Prodrug, Implants and Intrauterine Devices, Targeted Drug Delivery, Polymeric Drug Delivery and ... Read More
-
Global Generic Pharmaceuticals Market Size study & Forecast, by Type ( Simple Generics, Specialty Generics, Biosimilars), by Application ( Central Nervous System Disorders, Respiratory Diseases, Hormones & Related Diseases, Gastrointestinal Diseases, Cardiovascular Diseases, Infectious Diseases and Others), by Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable and Others), by Distribution Channel (Online Pharmacies, Hospitals Pharmacies, Retail Pharmacies)and Regional Analysis, 2023-2030
... and Others), by Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable and Others), by Distribution Channel (Online Pharmacies, Hospitals Pharmacies, Retail Pharmacies)and Regional Analysis, 2023-2030 Global Generic Pharmaceuticals Market is valued ... Read More
-
Neuroimaging Technology Advances and Growth Opportunities
... cure complex neurological disorders. Emerging MRI and CT technologies have helped address the challenges in neuroimaging, such as limited spatiotemporal resolution, cost and accessibility, and patient safety. This study examines emerging technologies, such as magnetic ... Read More
-
Global Cerebral Palsy Treatment Market - 2023-2030
... The global cerebral palsy treatment market is expected to exhibit a CAGR of 3.7% during the forecast period (2023-2030). The key players are adopting strategies such as partnerships, mergers, acquisitions, and regional expansion to stand ... Read More
-
Lewy Body Dementia (LBD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... than 1.1 million diagnosed prevalent cases of LBD in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. Currently, there are three marketed products for the treatment of LBD. R&D activity within the LBD ... Read More
-
Global Brain Health Functional Food and Beverage Market Growth 2023-2029
... is expected to grow at a CAGR of % from 2023 to 2029. United States market for Brain Health Functional Food and Beverage is estimated to increase from US$ million in 2022 to US$ million ... Read More
-
Global Psychedelic Drugs Market Size study & Forecast, by Drug Type (Gamma Hydroxybutyric Acid (GHB), Ketamine, Psilocybin, Lysergic Acid Diethylamide (LSD), 3 4-MethylEnedioxyMethamphetamine, Other Drug Types) by Application (Treatment Resistant Depression, Opiate Addiction, Post-traumatic Stress Disorder, Narcolepsy, Panic Disorders, Other Applications), By Distribution Channel ( Hospital pharmacy, Retail pharmacy and Other Distribution Channels) and Regional Analysis, 2022-2029
... Disorder, Narcolepsy, Panic Disorders, Other Applications), By Distribution Channel ( Hospital pharmacy, Retail pharmacy and Other Distribution Channels) and Regional Analysis, 2022-2029 Global Psychedelic Drugs Market is valued approximately USD XX billion in 2021 and ... Read More
-
Intracranial Stents Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures and Forecast to 2033
... and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Neurology Devices therapeutic area. The model discusses in detail the impact of COVID-19 on Intracranial ... Read More
-
ICP Monitoring Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures and Forecast to 2033
... Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Neurology Devices therapeutic area. The model discusses in detail the impact of COVID-19 ... Read More
-
Global Central Nervous System Biomarkers Market Size study & Forecast, by Type (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers, Others) by Application (Drug Discovery and Development, Personalized Medicine, Other Applications), by End User (Diagnostic Labs, Clinics/Hospitals, Research Centers) and Regional Analysis, 2022-2029
... Research Centers) and Regional Analysis, 2022-2029 Global Central Nervous System Biomarkers Market is valued approximately at USD 4.19 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.00% ... Read More
-
Global Sleep Aids Market Size study & Forecast, by Product (Mattress & Pillows, Sleep Laboratories, Medications, and Sleep Apnea Devices) by Sleep Disorders (Insomnia, Sleep Apnea, Restless Leg Syndrome, Narcolepsy, Sleepwalking, and Other Sleep Disorders) and Regional Analysis, 2022-2029
... and Regional Analysis, 2022-2029 Global Sleep Aids Market is valued approximately USD 63404.01 million in 2021 and is anticipated to grow with a healthy growth rate of more than 6.00% over the forecast period 2022-2029. ... Read More
-
Global Sleep Disorders Treatment Market Size study & Forecast, by Drug Type (Benzodiazepines, Nonbenzodiazepines, Antidepressants, and Other Drug Types) by Application (Insomnia, Sleep Apnea, Narcolepsy, Circadian disorders, and Other Applications) and Regional Analysis, 2022-2029
... Sleep Disorders Treatment Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. The sleep disorders treatment ... Read More
-
Europe Radioactive Tracers Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Test Type (PET, SPECT, and Others), End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others), Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], and Application (Oncology, Pulmonary, Neurology, Cardiology, and Others)
... [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, ... Read More
Research Assistance
